Maria B. Raeder

Bergen, Norway

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

The Short Cosyntropin Test Revisited: New Normal Reference Range Using LC-MS/MS.

The Short Cosyntropin Test Revisited: New Normal Reference Range Using LC-MS/MS.

Journal: The Journal of clinical endocrinology and metabolism

Published: December 01, 2017

ATAD2 overexpression links to enrichment of B-MYB-translational signatures and development of aggressive endometrial carcinoma.

ATAD2 overexpression links to enrichment of B-MYB-translational signatures and development of aggressive endometrial carcinoma.

Journal: Oncotarget

Published: April 07, 2015

Increased angiogenesis is associated with a 32-gene expression signature and 6p21 amplification in aggressive endometrial cancer.

Increased angiogenesis is associated with a 32-gene expression signature and 6p21 amplification in aggressive endometrial cancer.

Journal: Oncotarget

Published: January 19, 2015

Endometrial Carcinoma Recurrence Score (ECARS) validates to identify aggressive disease and associates with markers of epithelial-mesenchymal transition and PI3K alterations.

Endometrial Carcinoma Recurrence Score (ECARS) validates to identify aggressive disease and associates with markers of epithelial-mesenchymal transition and PI3K alterations.

Journal: Gynecologic oncology

Published: April 11, 2014

Lack of estrogen receptor-α is associated with epithelial-mesenchymal transition and PI3K alterations in endometrial carcinoma.

Lack of estrogen receptor-α is associated with epithelial-mesenchymal transition and PI3K alterations in endometrial carcinoma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: January 16, 2013

KRAS gene amplification and overexpression but not mutation associates with aggressive and metastatic endometrial cancer.

KRAS gene amplification and overexpression but not mutation associates with aggressive and metastatic endometrial cancer.

Journal: British journal of cancer

Published: October 27, 2012

Integrated genomic analysis of the 8q24 amplification in endometrial cancers identifies ATAD2 as essential to MYC-dependent cancers.

Integrated genomic analysis of the 8q24 amplification in endometrial cancers identifies ATAD2 as essential to MYC-dependent cancers.

Journal: PloS one

Published: September 28, 2012

Loss of GPER identifies new targets for therapy among a subgroup of ERα-positive endometrial cancer patients with poor outcome.

Loss of GPER identifies new targets for therapy among a subgroup of ERα-positive endometrial cancer patients with poor outcome.

Journal: British journal of cancer

Published: March 15, 2012

Lipocalin 2 expression is associated with aggressive features of endometrial cancer.

Lipocalin 2 expression is associated with aggressive features of endometrial cancer.

Journal: BMC cancer

Published: February 07, 2012

Obesity, dyslipidemia, and diabetes with selective serotonin reuptake inhibitors: the Hordaland Health Study.

Obesity, dyslipidemia, and diabetes with selective serotonin reuptake inhibitors: the Hordaland Health Study.

Journal: The Journal of clinical psychiatry

Published: December 30, 2006

Associations between cod liver oil use and symptoms of depression: the Hordaland Health Study.

Associations between cod liver oil use and symptoms of depression: the Hordaland Health Study.

Journal: Journal of affective disorders

Published: June 29, 2006

Showing 1-11 of 11

Last Updated: 09/26/2026